INTERCEPT PHARMACEUTICALS INC (ICPT) is a publicly traded company in the Unknown sector. Across all available filings, 39 corporate insiders have executed 1000 transactions totaling $860.6M, demonstrating a bearish sentiment with -$737.7M in net insider flow. The most recent transaction on Nov 8, 2023 involved a transaction of 23,021 shares valued at $437.4K.
No significant insider buying has been recorded for ICPT in the recent period.
No significant insider selling has been recorded for ICPT in the recent period.
Based on recent SEC filings, insider sentiment for ICPT is bearish with an Insider Alignment Score of 7/100 and a net flow of -$737.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at INTERCEPT PHARMACEUTICALS INC (ICPT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 39 insiders are actively trading ICPT stock, having executed 1000 transactions in the past 90 days. The most active insider is Francesco Micheli (Executive), who has made 7 transactions totaling $225.4M.
Get notified when executives and directors at ICPT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | Saik Andrew | Executive | Tender | 23,021 | $19.00 | $437.4K | |
| Nov 8, 2023 | Saik Andrew | Executive | Disposition | 45,244 | $19.00 | $859.6K | Large |
| Nov 8, 2023 | Pruzanski Mark | Executive | Tender | 618,894 | $19.00 | $11.8M | Large |
| Nov 8, 2023 | Benedict Durso Jerome | Executive | Disposition | 102,825 | $19.00 | $2.0M | Large |
| Nov 8, 2023 | Benedict Durso Jerome | Executive | Tender | 51,815 | $19.00 | $984.5K | Large |
| Nov 8, 2023 | Bradbury Daniel | Executive | Tender | 7,812 | $19.00 | $148.4K | |
| Nov 8, 2023 | Bradbury Daniel | Executive | Tender | 23,548 | $19.00 | $447.4K | |
| Nov 8, 2023 | Bradbury Daniel | Executive | Disposition | 8,111 | $19.00 | $154.1K | |
| Nov 8, 2023 | Freedberg Jared | Executive | Tender | 22,681 | $19.00 | $430.9K | |
| Nov 8, 2023 | Freedberg Jared | Executive | Disposition | 33,762 | $19.00 | $641.5K | Large |
| Nov 8, 2023 | A. Ford David | Executive | Tender | 15,038 | $19.00 | $285.7K | |
| Nov 8, 2023 | A. Ford David | Executive | Disposition | 21,400 | $19.00 | $406.6K | |
| Nov 8, 2023 | Michael Gottesdiener Keith | Executive | Disposition | 8,111 | $19.00 | $154.1K | |
| Nov 8, 2023 | Michael Gottesdiener Keith | Executive | Tender | 24,719 | $19.00 | $469.7K | |
| Nov 8, 2023 | Rosa-bjorkeson Dagmar | Executive | Disposition | 11,625 | $19.00 | $220.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 380 | $799.2M | 84.3% |
Purchase(P) | 17 | $61.5M | 6.5% |
Award(A) | 176 | $31.9M | 3.4% |
Tender(U) | 19 | $31.7M | 3.3% |
Payment(F) | 260 | $10.2M | 1.1% |
Disposition(D) | 16 | $7.1M | 0.7% |
Exercise(M) | 130 | $6.1M | 0.6% |
Gift(G) | 2 | $0 | 0.0% |
Insider selling pressure at INTERCEPT PHARMACEUTICALS INC has increased, with 39 insiders executing 1000 transactions across all time. Total sales of $799.2M significantly outpace purchases of $61.5M, resulting in a net outflow of $737.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.